The Defense Logistics Agency is planning a fully competitive, unrestricted national requirements contract for Dapagliflozin Tablets in 5 MG and 10 MG strengths, available in 30-count and 90-count bottles. The contract will be firm-fixed-price with a one-year base period and four one-year options, using commercial item procedures under FAR Part 12. It will establish a national supply source serving Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through DLA and VA prime vendor programs. Annual usage estimates will be provided in the solicitation, and all responsible sources may submit proposals. The current projected solicitation date is October 2026, with the solicitation to be posted on DIBBS and SAM.gov.